(APRIL 17, 2024) Randall Holcombe, M.D., M.B.A., director of the University of Vermont Cancer Center, discussed colorectal cancer in a Vermont Public interview.
Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, chief of the UVM Medical Center Division of Hematology/Oncology, and professor of medicine at the Larner College of Medicine
(APRIL 17, 2024) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, chief of the UVM Medical Center Division of Hematology/Oncology, and professor of medicine at the Larner College of Medicine, discussed colorectal cancer in a Vermont Public interview.
The third most common cancer for men and women in Vermont, colorectal cancer is the second leading cause of cancer-related death in the state, Holcombe said. But colorectal cancer is a preventable and highly treatable form of cancer—regular screenings can help detect it early and lead to higher survival rates.
“If it’s caught early and localized, then survival rate is about 80 percent at five years,” Holcombe said on Vermont Edition. “Unfortunately, if it’s found when it’s metastatic, or spread—that would be a Stage 4 cancer—then the five-year survival rate is only about 11 percent. So it makes a huge difference to try to catch the cancer early.”
Read full story
at
Vermont Public